RHEA B SANCASSANI

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease MIAMI, FL NPI 1003017112

General Payments — all program years on this page

$14,679.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 116
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,924.67 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $363.8219
2019 $196.3913
2020 $189.3711
2021 $283.0020
2022 $349.6018
2023 $7,372.6720
2024 $5,924.6715

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1081717114 Lexicon Pharmaceuticals, Inc. $23.05 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087300943 Novartis Pharmaceuticals Corporation $23.07 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087300947 Novartis Pharmaceuticals Corporation $20.76 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087300953 Novartis Pharmaceuticals Corporation $13.73 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087300955 Novartis Pharmaceuticals Corporation $19.49 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104383851 AstraZeneca Pharmaceuticals LP $20.00 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105473773 AstraZeneca Pharmaceuticals LP $21.65 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105728993 AstraZeneca Pharmaceuticals LP $18.00 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105835417 AstraZeneca Pharmaceuticals LP $14.35 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116084281 Amgen Inc. $17.58 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127580374 LANTHEUS MEDICAL IMAGING, INC. $25.00 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131562793 PFIZER INC. $5,640.00 01/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1132115391 PFIZER INC. $21.72 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154886066 Kiniksa Pharmaceuticals International, plc $24.67 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154886169 Kiniksa Pharmaceuticals International, plc $21.60 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.